KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Finished Goods: 2011-2020

Historic Finished Goods for Emergent BioSolutions (EBS) over the last 8 years, with Mar 2020 value amounting to $56.2 million.

  • Emergent BioSolutions' Finished Goods was N/A to $56.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $56.2 million, marking a year-over-year change of. This contributed to the annual value of $62.3 million for FY2019, which is 22.64% up from last year.
  • According to the latest figures from Q1 2020, Emergent BioSolutions' Finished Goods is $56.2 million, which was down 9.79% from $62.3 million recorded in Q4 2019.
  • In the past 5 years, Emergent BioSolutions' Finished Goods ranged from a high of $62.3 million in Q4 2019 and a low of $10.1 million during Q1 2017.
  • For the 3-year period, Emergent BioSolutions' Finished Goods averaged around $45.0 million, with its median value being $48.7 million (2018).
  • Per our database at Business Quant, Emergent BioSolutions' Finished Goods tumbled by 58.88% in 2017 and then spiked by 265.09% in 2018.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Finished Goods stood at $23.5 million in 2016, then rose by 28.12% to $30.1 million in 2017, then spiked by 68.77% to $50.8 million in 2018, then grew by 22.64% to $62.3 million in 2019, then reached $56.2 million in 2020.
  • Its Finished Goods stands at $56.2 million for Q1 2020, versus $62.3 million for Q4 2019 and $54.6 million for Q3 2019.